StanleyLeonHazenMD

Internal Medicine • Cleveland, OH

Endocrinology

Professor, Molecular Medicine, Case Western Reserve University School of Medicine. Preventative Cardiology

Join to view full profile

Dr. Hazen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hazen's full profile

Already have an account?

Office
9500 Euclid Ave
# Jb1
Cleveland, OH 44195
Phone+1 800-223-2273

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Endocrinology, Diabetes, and Metabolism, 1994 - 1996
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1992 - 1994
Washington University in St. Louis School of MedicineClass of 1992

Certifications & Licensure

OH State Medical License 1997 - 2026

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Elected Member The American Society for Clinical Investigation, 2003
Fellow (FACC) American College of Cardiology

Clinical Trials

GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease Start of enrollment: 2001 Jan 01
Active, not recruiting
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY) Start of enrollment: 2014 Apr 04
Recruiting
Not Applicable

Publications & Presentations

PubMed

Abbreviated Duke Activity Status Index for Risk Stratification in Heart Failure.
Silvio Nunes Augusto Jr, Yuping Wu, Thanat Chaikijurajai, Stanley L Hazen, W H Wilson Tang
The American Journal of Cardiology. 2025-02-15
Exploring the Role of Glycine Metabolism in Coronary Artery Disease: Insights from Human Genetics and Mouse Models.
Subarna Biswas, James R Hilser, Nicholas C Woodward, Zeneng Wang, Janet Gukasyan
Nutrients. 2025-01-06
Alcohol-induced gut microbial reorganization and associated overproduction of phenylacetylglutamine promotes cardiovascular disease.
Zhen Li, Min Gu, Aline Zaparte, Xiaoming Fu, Kala Mahen
Nature Communications. 2024-12-30

Journal Articles

Dietary Metabolism, the Gut Microbiome, and Heart Failure
Stanley L Hazen, Daniel Y Li, Nature
Development of a Gut Microbe–Targeted Nonlethal Therapeutic to Inhibit Thrombosis Potential
Stanley Hazen, MD, Nature
Elevated Levels of Plasma Symmetric Dimethylarginine and Increased Arginase Activity as Potential Indicators of Cardiovascular Comorbidity in Rheumatoid Arthritis
Stanley Hazen, MD, BioMed Central
Myeloperoxidase Aggravates Pulmonary Arterial Hypertension by Activation of Vascular Rho-Kinase
Stanley Hazen, MD, The Journal of Clinical Investigation
Join now to see all

Press Mentions

Long Covid: The Search for Answers Inches ForwardDecember 6th, 2024
Covid Can Raise the Risk of Heart Problems for YearsNovember 22nd, 2024
New Research Suggests Contracting This Disease Will Double Your Risk of a Heart AttackOctober 31st, 2024
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member